NORVIR (nda020659)- (80MG/ML)

Generic Name	RITONAVIR	Innovator	ABBVIE
Dosage	80MG/ML
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2016-Dec-26	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	NORVIR is HIV protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
80MG/ML	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of NORVIR